HomeINNPF • OTCMKTS
add
Innocan Pharma Corp
Previous close
$0.11
Year range
$0.091 - $0.19
Market cap
48.83M CAD
Avg Volume
333.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.80M | 15.19% |
Operating expense | 6.63M | -8.14% |
Net income | -582.00K | 67.06% |
Net profit margin | -7.47 | 71.39% |
Earnings per share | — | — |
EBITDA | 499.00K | 141.51% |
Effective tax rate | 793.94% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.36M | 38.52% |
Total assets | 10.82M | 19.66% |
Total liabilities | 3.93M | -9.32% |
Total equity | 6.89M | — |
Shares outstanding | 292.42M | — |
Price to book | 5.70 | — |
Return on assets | 12.18% | — |
Return on capital | 16.05% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -582.00K | 67.06% |
Cash from operations | 368.00K | 149.26% |
Cash from investing | -4.00K | -100.00% |
Cash from financing | 996.00K | -31.31% |
Net change in cash | 1.36M | 91.13% |
Free cash flow | 589.75K | -27.23% |
About
Founded
2018
Website
Employees
8
